ALAdam Leckenby

Adam Leckenby

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam Leckenby has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression and blocks myeloid differentiation

    by Aleksandra Azevedo, Adam Leckenby, Rachael Nicholson, Ana Catarina Menezes, Sara Davies, Amanda F Gilkes, Sarah Baker, Raymond Toghill, Ellie McCracken, Andrew Pierce, et al.

  • Open Access

    Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients

    by Matthew J. Wood, Adam Leckenby, Gary Reynolds, Rachel Spiering, Arthur G. Pratt, Kenneth S. Rankin, John D. Isaacs, Muzlifah A. Haniffa, Simon Milling, Catharien M.U. Hilkens

    Osteoarthritis (OA) is a leading cause of disability, globally. Despite an emerging role for synovial inflammation in OA pathogenesis, attempts to target inflammation therapeutically have had limited success. A better understanding of the cellular and molecular processes occurring in the OA synovium is needed to develop novel therapeutics. We investigated macrophage phenotype and gene expression in synovial tissue of OA and inflammatory-arthritis (IA) patients. Compared with IA, OA synovial tissue contained higher but variable proportions of macrophages ( P < 0.001). These macrophages exhibited an activated phenotype, expressing folate receptor-2 and CD86, and displayed high phagocytic capacity. RNA sequencing of synovial macrophages revealed 2 OA subgroups. Inflammatory-like OA (iOA) macrophages are closely aligned to IA macrophages and are characterized by a cell proliferation signature. In contrast, classical OA (cOA) macrophages display cartilage remodeling features. Supporting these findings, when compared with cOA, iOA synovial tissue contained higher proportions of macrophages ( P < 0.01), expressing higher levels of the proliferation marker Ki67 ( P < 0.01). These data provide new insight into the heterogeneity of OA synovial tissue and suggest distinct roles of macrophages in pathogenesis. Our findings could lead to the stratification of OA patients for suitable disease-modifying treatments and the identification of novel therapeutic targets.